Dominick Bossé

3.9k total citations · 1 hit paper
71 papers, 1.5k citations indexed

About

Dominick Bossé is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Dominick Bossé has authored 71 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 31 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Dominick Bossé's work include Renal cell carcinoma treatment (26 papers), Cancer Genomics and Diagnostics (20 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Dominick Bossé is often cited by papers focused on Renal cell carcinoma treatment (26 papers), Cancer Genomics and Diagnostics (20 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Dominick Bossé collaborates with scholars based in Canada, United States and Spain. Dominick Bossé's co-authors include Toni K. Choueiri, Joaquim Bellmunt, Aly‐Khan A. Lalani, Guillermo de Velasco, Patrick A. Ott, Raphael Brandão Moreira, Lauren C. Harshman, F. Stephen Hodi, Rana R. McKay and Fabio A.B. Schutz and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Dominick Bossé

66 papers receiving 1.5k citations

Hit Papers

Comprehensive Meta-analysis of Key Immune-Related Adverse... 2017 2026 2020 2023 2017 100 200 300

Peers

Dominick Bossé
C. Zielinski Austria
Emily Z. Keung United States
Maureen Reiner United States
Jiajia Zhang United States
Silvia Park South Korea
Mary Ruisi United States
Mathew M. Augustine United States
Zhishen Ye United States
Carmel Stock United Kingdom
Dominick Bossé
Citations per year, relative to Dominick Bossé Dominick Bossé (= 1×) peers John Wen‐Cheng Chang

Countries citing papers authored by Dominick Bossé

Since Specialization
Citations

This map shows the geographic impact of Dominick Bossé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominick Bossé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominick Bossé more than expected).

Fields of papers citing papers by Dominick Bossé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominick Bossé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominick Bossé. The network helps show where Dominick Bossé may publish in the future.

Co-authorship network of co-authors of Dominick Bossé

This figure shows the co-authorship network connecting the top 25 collaborators of Dominick Bossé. A scholar is included among the top collaborators of Dominick Bossé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominick Bossé. Dominick Bossé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamilou, Zineb, Sunita Ghosh, Daniel Yick Chin Heng, et al.. (2025). Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma. The Oncologist. 30(9). 1 indexed citations
3.
Brown, Carl J., C. O'Callaghan, Jonathan M. Loree, et al.. (2024). 565P Neoadjuvant chemotherapy, excision, and observation for early rectal cancer: The phase II NEO trial (CCTG CO.28) results after minimum 3 years follow up. Annals of Oncology. 35. S462–S463.
4.
Ghosh, Sunita, Lori Wood, Georg A. Bjarnason, et al.. (2024). Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database. Current Oncology. 31(8). 4704–4712. 3 indexed citations
5.
Ghosh, Sunita, Antonio Finelli, Lori Wood, et al.. (2023). Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care System. JCO Global Oncology. 9(9). e2300271–e2300271. 1 indexed citations
7.
McAlpine, Kristen, Marc Carrier, Dominick Bossé, et al.. (2022). Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer. Urologic Oncology Seminars and Original Investigations. 40(8). 381.e1–381.e7. 4 indexed citations
8.
Kanji, Salmaan, et al.. (2022). Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic Reviews. Drugs. 82(7). 793–809. 9 indexed citations
9.
Bossé, Dominick, et al.. (2020). Imaging Intensity and Survival Outcomes in High-Risk Resected Melanoma Treated by Systemic Therapy at Recurrence. Annals of Surgical Oncology. 27(10). 3683–3691. 12 indexed citations
10.
Kushnir, Igal, Ranjeeta Mallick, Michael Ong, et al.. (2020). Docetaxel dose-intensity effect on overall survival in patients with metastatic castrate-sensitive prostate cancer. Cancer Chemotherapy and Pharmacology. 85(5). 863–868. 4 indexed citations
11.
McKay, Rana R., Dominick Bossé, Kathryn P. Gray, et al.. (2018). Radium-223 Dichloride in Combination with Vascular Endothelial Growth Factor–Targeting Therapy in Advanced Renal Cell Carcinoma with Bone Metastases. Clinical Cancer Research. 24(17). 4081–4088. 26 indexed citations
12.
Lalani, Aly‐Khan A., Wanling Xie, Dylan J. Martini, et al.. (2018). Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 6(1). 5–5. 197 indexed citations
13.
Velasco, Guillermo de, Youjin Je, Dominick Bossé, et al.. (2017). Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients. Cancer Immunology Research. 5(4). 312–318. 369 indexed citations breakdown →
14.
Sevillano, Elena, Lillian Werner, Dominick Bossé, et al.. (2017). Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non–Lymph Node Distant Metastasis. Clinical Genitourinary Cancer. 15(6). e1089–e1094. 4 indexed citations
15.
Chen, Fengju, Yiqun Zhang, Dominick Bossé, et al.. (2017). Pan-urologic cancer genomic subtypes that transcend tissue of origin. Nature Communications. 8(1). 199–199. 48 indexed citations
16.
Bossé, Dominick, Kathryn P. Gray, M. Dror Michaelson, et al.. (2017). Pazopanib (p) or sorafenib (s) + radium-223 (rad) in metastatic renal cell carcinoma (mrcc) with bone metastases (bm). Annals of Oncology. 28. v299–v299. 2 indexed citations
17.
Bossé, Dominick, Esmeralda Celia Marginean, D. Blair Macdonald, Garth Nicholas, & Shailendra Verma. (2016). Tumour Lysis Syndrome in Solid Tumours Associated with Tyrosine Kinase Inhibitors – A Case Illustrated Review. European Oncology & Haematology. 12(1). 51–51.
18.
Bossé, Dominick, Soundouss Raissouni, Kristopher Dennis, et al.. (2016). PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer Consortium. Clinical Colorectal Cancer. 15(3). 243–249. 21 indexed citations
19.
Bossé, Dominick, Roula Albadine, Jean‐Paul Praud, et al.. (2011). Total liquid ventilation efficacy in an ovine model of severe meconium aspiration syndrome. Critical Care Medicine. 39(5). 1097–1103. 19 indexed citations
20.
Bossé, Dominick, Hervé Walti, Raymond Robert, et al.. (2010). Experimental Validation of Cardiac Index Measurement Using Transpulmonary Thermodilution Technique in Neonatal Total Liquid Ventilation. ASAIO Journal. 56(6). 557–562. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026